Author Correction: Non-transcriptional control of DNA replication by c-Myc (Nature, (2007), 448, 7152, (445-451), 10.1038/nature05953);Non-transcriptional control of DNA replication by c-Myc

Nature

Volumn 448, Issue 7152, 2007, Pages 445-451

  Dominguez Sola, David ^a   Ying, Carol Y ^a   Grandori, Carla ^b,c   Ruggiero, Luca ^a   Chen, Brenden ^a   Li, Muyang ^a   Galloway, Denise A ^b   Gu, Wei ^a   Gautier, Jean ^a   Dalla Favera, Riccardo ^a  

^a New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c ROSETTA INPHARMATICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RNA;

CYTOLOGY; DNA; GROWTH; MAMMAL; TUMOR;

ANIMAL CELL; ARTICLE; CELL FREE SYSTEM; CONTROLLED STUDY; DNA DAMAGE; DNA REPLICATION; DNA SYNTHESIS; GENE ACTIVITY; GENE FUNCTION; GENE INTERACTION; GENE LOCATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MAMMAL CELL; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; RNA TRANSCRIPTION; TRANSCRIPTION REGULATION; XENOPUS;

MAMMALIA;

EID: 34547232986     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/s41586-023-06284-1     Document Type: Erratum

References (54)

1. Dalla-Favera, R. et al. Cloning and characterization of different human sequences related to the onc gene (v-myc) of avian myelocytomatosis virus (MC29). Proc. Natl Acad. Sci. USA 79, 6497-6501 (1982).
2. Vennstrom, B., Sheiness, D., Zabielski, J. & Bishop, J. M. Isolation and characterization of c-myc, a cellular homolog of the oncogene (v-myc) of avian myelocytomatosis virus strain 29. J. Virol. 42, 773-779 (1982).
3. Grandori, C., Cowley, S. M., James, L. P. & Eisenman, R. N. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16, 653-699 (2000).
4. Fernandez, P. C. et al. Genomic targets of the human c-Myc protein. Genes Dev. 17, 1115-1129 (2003).
5. Patel, J. H., Loboda, A. P., Showe, M. K., Showe, L. C. & McMahon, S. B. Analysis of genomic targets reveals complex functions of MYC. Nature Rev. Cancer 4, 562-568 (2004).
6. Dalla-Favera, R. et al. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc. Natl Acad. Sci. USA 79, 7824-7827 (1982).
7. Dalla-Favera, R., Wong-Staal, F. & Gallo, R. C. Onc gene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemic cells of the same patient. Nature 299, 61-63 (1982).
8. Pasqualucci, L. et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412, 341-346 (2001).
9. Collins, S. & Groudine, M. Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line. Nature 298, 679-681 (1982).
10. Adams, J. M. et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318, 533-538 (1985).
11. Pelengaris, S., Khan, M. & Evan, G. c-MYC: more than just a matter of life and death. Nature Rev. Cancer 2, 764-776 (2002).
12. Wade, M. & Wahl, G. M. c-Myc, genome instability, and tumorigenesis: the devil is in the details. Curr. Top. Microbiol. Immunol. 302, 169-203 (2006).
13. Machida, Y. J., Hamlin, J. L. & Dutta, A. Right place, right time, and only once: replication initiation in metazoans. Cell 123, 13-24 (2005).
14. Gilbert, D. M. In search of the holy replicator. Nature Rev. Mol. Cell Biol. 5, 848-855 (2004).
15. Iguchi-Ariga, S. M., Itani, T., Kiji, Y. & Ariga, H. Possible function of the c-myc product: promotion of cellular DNA replication. EMBO J. 6, 2365-2371 (1987).
16. Obaya, A. J., Mateyak, M. K. & Sedivy, J. M. Mysterious liaisons: the relationship between c-Myc and the cell cycle. Oncogene 18, 2934-2941 (1999).
17. Koch, H. B. et al. Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. Cell Cycle 6, 205-217 (2007).
18. McMahon, S. B., Van Buskirk, H. A., Dugan, K. A., Copeland, T. D. & Cole, M. D. The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell 94, 363-374 (1998).
19. Zhang, J. J. et al. Ser727-dependent recruitment of MCM5 by Stat1α in IFN-γ-induced transcriptional activation. EMBO J. 17, 6963-6971 (1998).
20. Facchini, L. M., Chen, S., Marhin, W. W., Lear, J. N. & Penn, L. Z. The Myc negative autoregulation mechanism requires Myc-Max association and involves the c-myc P2 minimal promoter. Mol. Cell. Biol. 17, 100-114 (1997).
21. Grignani, F. et al. Negative autoregulation of c-myc gene expression is inactivated in transformed cells. EMBO J. 9, 3913-3922 (1990).
22. Abdurashidova, G. et al. Start sites of bidirectional DNA synthesis at the human lamin B2 origin. Science 287, 2023-2026 (2000).
23. Tao, L., Dong, Z., Leffak, M., Zannis-Hadjopoulos, M. & Price, G. Major DNA replication initiation sites in the c-myc locus in human cells. J. Cell. Biochem. 78, 442-457 (2000).
24. Prathapam, T., Tegen, S., Oskarsson, T., Trumpp, A. & Martin, G. S. Activated Src abrogates the Myc requirement for the G0/G1 transition but not for the G1/S transition. Proc. Natl Acad. Sci. USA 103, 2695-2700 (2006).
25. Rao, P. N. & Johnson, R. T. Mammalian cell fusion: studies on the regulation of DNA synthesis and mitosis. Nature 225, 159-164 (1970).
26. Blow, J. J. & Laskey, R. A. Initiation of DNA replication in nuclei and purified DNA by a cell-free extract of Xenopus eggs. Cell 47, 577-587 (1986).
27. Walter, J., Sun, L. & Newport, J. Regulated chromosomal DNA replication in the absence of a nucleus. Mol. Cell 1, 519-529 (1998).
28. Grandori, C. et al. c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nature Cell Biol. 7, 311-318 (2005).
29. Woodward, A. M. et al. Excess Mcm2-7 license dormant origins of replication that can be used under conditions of replicative stress. J. Cell Biol. 173, 673-683 (2006).
30. Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S. & Bonner, W. M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273, 5858-5868 (1998).
31. Costanzo, V. et al. Mre11 protein complex prevents double-strand break accumulation during chromosomal DNA replication. Mol. Cell 8, 137-147 (2001).
32. McGarry, T. J. & Kirschner, M. W. Geminin, an inhibitor of DNA replication, is degraded during mitosis. Cell 93, 1043-1053 (1998).
33. Wang, X. et al. Role of DNA replication proteins in double-strand break-induced recombination in Saccharomyces cerevisiae. Mol. Cell. Biol. 24, 6891-6899 (2004).
34. Shechter, D., Costanzo, V. & Gautier, J. ATR and ATM regulate the timing of DNA replication origin firing. Nature Cell Biol. 6, 648-655 (2004).
35. Kovalchuk, A. L. et al. Burkitt lymphoma in the mouse. J. Exp. Med. 192, 1183-1190 (2000).
36. Knoepfler, P. S. et al. Myc influences global chromatin structure. EMBO J. 25, 2723-2734 (2006).
37. Norio, P. DNA replication: the unbearable lightness of origins. EMBO Rep. 7, 779-781 (2006).
38. Bartkova, J. et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, 864-870 (2005).
39. Gorgoulis, V. G. et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434, 907-913 (2005).
40. Felsher, D. W. & Bishop, J. M. Transient excess of MYC activity can elicit genomic instability and tumorigenesis. Proc. Natl Acad. Sci. USA 96, 3940-3944 (1999).
41. Mai, S. & Mushinski, J. F. c-Myc-induced genomic instability. J. Environ. Pathol. Toxicol. Oncol. 22, 179-199 (2003).
42. Grandori, C. et al. Werner syndrome protein limits MYC-induced cellular senescence. Genes Dev. 17, 1569-1574 (2003).
43. Cobb, J. A. et al. Replisome instability, fork collapse, and gross chromosomal rearrangements arise synergistically from Mec1 kinase and RecQ helicase mutations. Genes Dev. 19, 3055-3069 (2005).
44. Di Micco, R. et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444, 638-642 (2006).
45. Felsher, D. W., Zetterberg, A., Zhu, J., Tlsty, T. & Bishop, J. M. Overexpression of MYC causes p53-dependent G2 arrest of normal fibroblasts. Proc. Natl Acad. Sci. USA 97, 10544-10548 (2000).
46. McCormack, S. J. et al. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability. Oncogene 16, 2755-2766 (1998).
47. Nikolaev, A. Y. Li, M. Puskas, N., Qin, J. & Gu, W. Parc: a cytoplasmic anchor for p53. Cell 112, 29-40 (2003).
48. Grandori, C, et al. c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nature Cell Biol. 7, 311-318 (2005).
49. Smythe, C&. Newport, J. W. Systems for the study of nuclear assembly, DNA replication, and nuclear breakdown in Xenopus laevis egg extracts. Methods Cell Biol. 35, 449-468 (1991).
50. Walter, J. Sun, L. & Newport, J. Regulated chromosomal DNA replication in the absence of a nucleus. Mol Cell 1, 519-529 (1998).
51. Michael, W. M. Ott, R. Fanning, E. & Newport, J. Activation of the DNA replication checkpoint through RNA synthesis by primase. Science 289, 2133-2137 (2000).
52. Hickson, I, et al. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res 64, 9152-9159 (2004).
53. Jackson, J. R, et al. An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage. Cancer Res 60, 566-572 (2000).
54. Kovalchuk, A. L, et al. Burkitt lymphoma in themouse. J. Exp. Med. 192, 1183-1190 (2000).